Ovarian Hyperstimulation Syndrome - 25 Studies Found

Not yet recruiting : Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome
: Ovarian Hyperstimulation Syndrome
: 2016-07-14
:
  • Drug: bromocriptine Patients i
Completed : Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome
: Ovarian Hyperstimulation Syndrome
: 2009-11-13
:
  • Drug: Methylprednisolone Admin
Completed : The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors
: Ovarian Hyperstimulation Syndrome
: 2009-03-21
: Drug: Cetrotide acetate cetrotide acetate is a GnRH antagonist. The dose is 3 mg once on the day of oocy
Withdrawn : The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome
: Ovarian Hyperstimulation Syndrome
: 2008-02-05
:
  • Drug: Human Albumin Infusion G
Withdrawn : Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)
: Ovarian Hyperstimulation Syndrome
: 2015-03-13
:
  • Drug: cetrorelix (cetrotide) 0
Active, not recruiting : Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers
: Ovarian Hyperstimulation Syndrome
: 2012-02-15
:
  • Drug: Cabergoline Cabergoline

Completed : Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome
: Ovarian Hyperstimulation Syndrome
: 2008-04-18
: Drug: Quinagolide • Quinagolide 200 μg/day (dos
Completed : Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.
: Ovarian Hyperstimulation Syndrome (OHSS)
: 2012-10-03
: Other: Highly purified menotropin (HP- hMG) treatment No intervention: patients treated by highly purifi
Recruiting : The Influence of Timing of Cabergoline Initiation on Prevention of OHSS
: Ovarian Hyperstimulation Syndrome
: 2015-11-24
:
  • Drug: Late Cabergoline 0.5mg C
Completed : Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist
: Ovarian Hyperstimulation Syndrome
: 2009-02-02
Next >>>